India's Zydus begins human trials for potential Covid-19 vaccine

Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential Covid-19 vaccine. ​​ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said. In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.

Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential Covid-19 vaccine. ​​ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said. In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India. from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/2ZtUpbd
via IFTTT
India's Zydus begins human trials for potential Covid-19 vaccine India's Zydus begins human trials for potential Covid-19 vaccine Reviewed by Krishblog on July 15, 2020 Rating: 5

No comments:

Powered by Blogger.